Mini Networking Night on Medical Affairs 

Event details
Join us for an evening of networking for research trainees interested in Careers in Medical Affairs. With a guest to student ratio of 1:5, students can participate in engaging conversations in an relaxed atmosphere
Date: Wednesday, August 26th, 2015
Time: 6:00 pm – 8:00 pm
Location: 2nd floor of Prenup Pub (191 College St, Toronto), near Queen’s Park Subway Station
 
Event program
6:00 – 6:10 p.m. Registration
6:10 – 6:20 p.m. Welcome remarks & Guest introduction
6:20 – 7:20 p.m. Structured Networking (students are organized into groups, which rotate every 20 minutes)
7:20 – 8:00 p.m. Open Networking
*Appetizers & cash bar are provided.
 
Note: Please follow us on social media (FacebookLinkedIn and Twitter). The call for registration for all events in the Mini-Networking Series will first go out on social media.

Very limited space available. Registered individuals who do not show up will be prevented from registering for future events.

The Mini Networking Series is free for all students, post-docs and other research trainees at the University of Toronto or the affiliated research institutions. External participants must pay a $5 fee to register.

Have more questions about registration? Visit our FAQ page.

Guests

Dennis Wagner PhD,

Medical Science Liaison, Gilead Sciences

Dr. Dennis Wagner joined Gilead Sciences Inc. in Jan 2015 as a Medical Science Liaison (MSL). Prior to that (2012-2014), Dennis served as an MSL and later as a Scientific Advisor at GlaxoSmithKline Inc (GSK). In both MSL roles, Dennis provided scientific/clinical support and expertise to key external physicians/HCPs focusing on oncology/hematology. Dennis completed his PhD at the University of Toronto, where he directed a clinical trial of vitamin D supplementation in prostate cancer patients undergoing prostate surgery. While pursuing his PhD, Dennis also co-founded and managed a small consulting firm that provided contract consulting support to management consulting firms and life science companies. He also served as a co-president of the Life Sciences Career Development Society (LSCDS) at the University of Toronto. Outside of work, Dennis enjoys playing tennis and soccer, as well as traveling to new destinations to experience unique cultures and cuisines.

Eva Sulatycki PhD

Medical Affairs Associate, GlaxoSmithKline Inc.

Eva Razumienko completed her undergraduate degree at the University of Toronto, and is currently completing her PhD in the Faculty of Pharmacy. As part of her thesis research she worked to develop novel Nuclear Imaging probes for diagnosis and treatment of Breast Cancer. She has published 4 peer reviewed publications, and has won speaking awards at many local and national conferences. The results of her research are currently being transitioned into a Phase I clinical study, a result of the emphasis she put on bringing her work from bench to bedside. She joined GSK in early 2014 as a Medical Affairs Associate in Vaccines, before moving into her role as an MSL in Respiratory last October.

Paul Nagy PhD

Medical Science Liaison, GlaxoSmithKline Inc.

Paul Nagy is a Medical Science Liaison at GlaxoSmithKline (GSK) who focuses on therapeutics for respiratory diseases.

Paul Nagy received his BSc in Biochemistry from Carleton University (2007) and PhD in Laboratory Medicine and Pathobiology from the University of Toronto (2014) where his research focused on cholinergic regulation of neurotransmission in central and peripheral pathways. He has published in peer-reviewed journals including the Journal of Neuroscience and has delivered a number of scientific presentations at international congresses including Experimental Biology.

Prior to joining GSK, Paul worked as a preclinical Research Manager at the Sunnybrook Research Institute in Toronto, Ontario. In that position, he developed translational approaches to circumvent the blood-brain-barrier for therapeutic delivery. As part of this role, Paul liaised with an expansive network of scientific and technical collaborators.

Before that, Paul has worked for the Medical Affairs and Clinical Operations teams at ApoPharma Inc, the innovative drug division of Apotex Inc, where he contributed to the haematology, dermatology and neurodegenerative therapeutic areas.